IgA vasculitis post-ChAdOx1 nCoV-19 vaccine in a patient with rheumatoid arthritis

IgA vasculitis post-ChAdOx1 nCoV-19 vaccine in a patient with rheumatoid arthritis

Saved in:

Bibliographic Details
Main Authors:	Kunal Chandwar, Digvijay Gajanan Ekbote, Juhi Dixit, Kriti Kishor, Kiran Preet Malhotra, Urmila Dhakad
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-01-01
Series:	Indian Journal of Rheumatology
Subjects:	rheumatoid arthritis iga vasculitis covid-19 chadox1 ncov-19 (chimpanzee adenovirus-vectored) vaccine
Online Access:	http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=186;epage=187;aulast=
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hemophagocytic Lymphohistiocytosis after ChAdOx1 nCoV-19 Coronavirus Vaccination in a Patient with no Known Comorbidities
by: Nitin Rai, et al.
Published: (2022-10-01)

Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population
by: Sukhpal Kaur, et al.
Published: (2025-01-01)

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study
by: Hiam Chemaitelly, et al.
Published: (2025-08-01)

Transcriptomic and miRNA Signatures of ChAdOx1 nCoV-19 Vaccine Response Using Machine Learning
by: Jinting Lin, et al.
Published: (2025-06-01)

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
by: Prasad S. Kulkarni, et al.
Published: (2024-12-01)

Antibody Response against SARS-CoV-2 Following ChAdOx1(Astezeneca AZD 1222) Vaccine in Health Care Workers in a Tertiary Care Hospital in India
by: Felice FAIZAL, et al.
Published: (2021-09-01)

Profile of Humoral Immunity and B Cell Pool in Infection with the SARS-CoV-2 Prototype Strain and AZD1222 (ChAdOx nCoV-19) Vaccination
by: Débora Familiar-Macedo, et al.
Published: (2025-01-01)

Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)Research in context
by: Sandra Belij-Rammerstorfer, et al.
Published: (2025-08-01)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
by: Edmund G.-T. Wee, et al.
Published: (2024-08-01)

Serosurveillance among healthcare workers vaccinated with ChAdOx1 nCoV-19 Corona vaccine in a tertiary hospital of Kerala, India: prospective cohort studу
by: S. K. Njarekkattuvalappil, et al.
Published: (2021-10-01)

Single ChAdOx1 nCoV‐19 dose elicits stronger immune response in previously infected individuals than in SARS‐CoV2 naive persons
by: Fawzi Ebrahim, et al.
Published: (2024-01-01)

Cytotoxic Lesion of Corpus Callosum after COVID-19 Vaccination: Case Report
by: Wan-Ling Chang, et al.
Published: (2024-04-01)

Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population
by: Anuradha Nadda, et al.
Published: (2025-06-01)

The perils of generic small molecules: Has tofacitinib become a toffee
by: Kunal Chandwar, et al.
Published: (2022-01-01)

COVID-19 anniversary – The hits, the misses, and the way forward: A resident's view
by: Kunal Chandwar, et al.
Published: (2021-01-01)

Quadriparesis with different diagnoses after COVID-19 vaccination: Case series and literature review
by: Sachin Wali, et al.
Published: (2023-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
by: L. V. Cherenova, et al.
Published: (2017-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
by: L. V. Cherenova, et al.
Published: (2017-05-01)

Nursing experience of treating a critical ill patient with novel coronavirus (2019-nCoV) infected pneumonia by using ECMO
by: Jing MA, et al.
Published: (2020-02-01)

The legal class B infectious disease - the 2019 novel coronavirus (2019-nCoV) infected pneumonia in Wuhan, China: a review
by: Li LI, et al.
Published: (2020-02-01)

SARS and MERS as learning tools for addressing the 2019-nCoV epidemic: A mini-review
by: Udit DAVE, et al.
Published: (2020-07-01)

Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study
by: Tiffany Dyu, et al.
Published: (2024-12-01)

Thrombosis with thrombocytopenia after first dose of ChAdOx1 nCoV-19 vaccine: a case report
by: K. Kolodynskaja, et al.
Published: (2021-12-01)

Experience in nursing of newborn with suspected novel coronavirus (2019-nCoV) infected pneumonia in neonatal intensive care unit
by: Na LI, et al.
Published: (2020-02-01)

Cutaneous Leukocytoclastic Vasculitis after ChAdOx1 nCoV-19 Vaccine
by: Mansoor C. Abdulla
Published: (2022-10-01)

Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
by: Amit Roy, et al.
Published: (2022-01-01)

Two cases of adult-onset de novo immunoglobulin A vasculitis with nephritis: Post-Covishield (ChAdOx1 nCoV-19; Oxford–Astra Zeneca) vaccination
by: Vijoy Kumar Jha, et al.
Published: (2022-01-01)

Understanding mechanisms of thrombosis and thrombocytopenia with adenoviral SARS-CoV-2 vaccines: a comprehensive synopsis
by: Phillip LR Nicolson, et al.
Published: (2025-07-01)

Salivary gland involvement in granulomatosis with polyangiitis: Case report and review of literature
by: Kunal Chandwar, et al.
Published: (2023-01-01)

Immunomodulatory responses of toll like receptors against 2019nCoV
by: Amany Sayed Maghraby
Published: (2021-06-01)

Diagnosis of Covid-19 in Children and Nursing Approach: A Systematic Review
by: Emine Sarman, et al.
Published: (2021-04-01)

Safety and immunogenicity of Ad5-nCoV administered intradermally by needle-free injector in rats
by: Li Chen, et al.
Published: (2025-02-01)

Impact of population movement on the spread of 2019-nCoV in China
by: Chi Zhang, et al.
Published: (2020-01-01)

Simulation of epidemic trends of 2019-nCoV epidemic trend under effective control measures
by: Ru-Hai BAI, et al.
Published: (2020-04-01)

Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohorts
by: Aidibai Simayi, et al.
Published: (2024-12-01)

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
by: Wei Zhang, et al.
Published: (2020-01-01)

Impact of ChAdOx1 nCoV-19 (Covishield™) Vaccination: How Long Will It Persist?
by: Leimapokpam Sumitra Devi, et al.
Published: (2022-01-01)

A novel chimpanzee adenovirus vector vaccine for protection against infectious bronchitis and Newcastle disease in chickens
by: Chengyao Hou, et al.
Published: (2025-05-01)

Analyzing internet public sentiment of the novel coronavirus (2019-nCoV) base on Python crawler from Post Bar and its countermeasures
by: Hui GENG, et al.
Published: (2020-04-01)

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version)
by: Ying-Hui JIN, et al.
Published: (2020-02-01)